期刊文献+

高级别胶质瘤假性进展的功能MRI研究 被引量:3

Functional MRI in the evaluation of pseudoprogression of high grade glioma
下载PDF
导出
摘要 高级别胶质瘤(HGG)治疗后可发生假性进展,但常规MRI对HGG假性进展的诊断价值有限。目前多种功能MRI技术已用于HGG假性进展与真性进展的鉴别诊断,包括扩散成像、^(1)H-MR波谱成像(MRS)、灌注加权成像(PWI)、酰胺质子转移成像(APT)等,联合这些功能MRI技术及人工智能可进一步改善诊断效能。就这些功能成像及其参数在假性进展方面的研究进展进行综述。 Pseudoprogression of high-grade glioma(HGG) may occur after treatment,but conventional MRI imaging has limited diagnostic value for pseudoprogression of HGG.At present,a variety of functional MRI techniques,including diffusion imaging,^(1)H-MR spectroscopy(MRS),perfusion weighted imaging(PWI),and amide proton transfer imaging(APT),etc.,have been used for the differential diagnosis between HGG pseudoprogression and true progression.The combination of these functional MRI techniques and artificial intelligence can further improve the diagnostic efficiency.This article reviews the research progress of these functional MRI techniques and their imaging parameters in pseudoprogression.
作者 张可心 袁涛 王颖杰 全冠民 ZHANG Kexin;YUAN Tao;WANG Yingjie;QUAN Guanmin(Department of Medical Imaging,Second Hospital of Hebei Medical University,Shijiazhuang 050000,China;CT/MR Department,People Hospital of Xingtai)
出处 《国际医学放射学杂志》 北大核心 2022年第3期298-302,共5页 International Journal of Medical Radiology
基金 河北省政府2018年资助专科带头人培养资助项目(361004) 河北省医学适用技术跟踪项目(G201725)。
关键词 高级别胶质瘤 假性进展 磁共振成像 功能成像 鉴别 High grade gliomas Pseudoprogression Magnetic resonance imaging Functional imaging Differential diagnosis
  • 相关文献

参考文献4

二级参考文献27

  • 1Louis DN, Ohgaki H, Wiestler OD, et al. WHO classification of turnouts of the central nervous system [ J ]. Acta Neuropathol, 2007, 114(2) : 97-109.
  • 2Kim HS, Kim SY. A prospective study on the added value of pulsed arterial spin-labeling and apparent diffusion coefficients in the grading of gliomas [ J ]. American Journal of Neuroradiology, 2007, 28(9) : 1693-1699.
  • 3Hoffman WF, Levin VA, Wilson CB, et al. Evaluation of malig- nant glioma patients during the postirradiation period [ J ]. Jour- nal of neurosurgery, 1979, 50 (5) :624-628.
  • 4deWit MC, de Brain HG, Eijkenboom W, et al. Immediate postra- diotherapy changes in malignant glioma can mimic tumor progres- sion [J]. Neurology, 2004, 63(3):535-537.
  • 5Brandsma D, Stalpers L, Taal W, et al. Clinical features, mech- anismsand management of pseudoprogression in malignant glioma [J]. Lancet Oneol, 2008, 9(5): 453-461.
  • 6Van Mieghem E, Wozniak A, Geussens Y, et al. Defining pseu- doprogression in glioblastomamuhiforme [ J 1. Eur J Neurol, 2013, 20(10) : 1335-1341.
  • 7Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma [ J]. N Engl J Med, 2005, 352(10) : 987-996.
  • 8Oborski MJ, Laymon CM, Lieberman FS, et al. Distingnishingp- seudoprogression from progression in high-grade gliomas: a brief review of current clinical practice and demonstration of the poten- tial value of ^18F-FDG PET [ J ]. Journal of Nuclear Materials, 2013, 38(5) : 381-384.
  • 9Mangla R, Ginat DT, Kamalian S, et al. Correlation between progression free survival and dynamic susceptibility contrast MRI perfusion in WHO grade Ⅲ glioma subtypes [ J]. Journalof Neu- ro-Oncology, 2014, 116(2) : 325-331.
  • 10Algizawiy M, Prah M, Mueller W, et al. DSC-MRI measures of rCBV predict tumor characteristics beyond stardard histopathology [Jl. Neuro-Oncology, 2014, 16(5) : 138-158.

共引文献42

同被引文献20

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部